Introduction {#Sec1}
============

Mitochondrial dysfunction due to impaired oxidative phosphorylation has been implicated as a major factor in the pathogenesis of several neurodegenerative disorders. It has, for example, been associated with defects in various mitochondrial respiratory chain or related complexes in Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD), and Friedreich's ataxia (Schapira [@CR24]). Reductions in activities of both mitochondrial complex I(CI) (Schapira et al. [@CR25], [@CR26]) and the TCA cycle enzyme alpha-ketoglutarate dehydrogenase (KGDH) (Mizuno et al. [@CR19]) which provides substrate for the complex are in fact physiological hallmarks associated with human PD neuropathology.

Elevations in the catecholamine-oxidizing enzyme monoamine oxidase-B (MAO-B) have been suggested to contribute to PD neuropathology (Cohen and Kesler [@CR4]). Substrate oxidation by the enzyme is accompanied stoichiometrically by the reduction of oxygen to H~2~O~2~ which in turn can lead to cellular damage (Vindis et al. [@CR34]; Cohen et al. [@CR5]). We previously demonstrated that subtle increases in MAO-B levels mimicking those which occur with age in a genetically engineered dopaminergic PC12 cell line resulted in increased H~2~O~2~ production and selective decreases in the activities of both CI and KGDH (Kumar et al. [@CR13]). MAO-B elevation was found to abolish the spare KGDH threshold capacity that normally requires significant inhibition before affecting maximal mitochondrial oxygen consumption rates. This in turn was found to compromise the ability of dopaminergic neurons to cope with increased energetic stress.

Various additional metabolic pathway components may also be impacted by oxidative stress as a consequence of MAO-B increase resulting in a cumulative disruptive effect on general mitochondrial respiratory function. The activity of any single component enzyme must be inhibited, however, to a particular threshold level before it affects metabolism as a whole (i.e., each enzyme has a 'reserve capacity') (Rossignol et al. [@CR22]). Stress conditions (such as increased oxidative stress) can change the reserve capacities of mitochondrial enzymes and, by doing so, may compromise the cell's ability to maintain metabolic function. Here we attempt to more fully characterize the impact of MAO-B elevation on mitochondrial bioenergetics. We investigated the respiratory thresholds of several possible contributors to NADH levels as a substrate for cellular respiration including the mitochondrial electron transfer chain enzymes CI and CII (SDH) and the TCA cycle enzymes aconitase, KGDH, and pyruvate dehydrogenase (PDH). We measured both basal respiratory thresholds and losses in spare capacities of these enzymes in the oxidative stress condition derived from H~2~O~2~ generation as a consequence of MAO-B elevation in our model system.

Materials and Methods {#Sec2}
=====================

All chemicals were obtained from Sigma unless and otherwise noted.

Doxycycline (dox)-Inducible MAO-B Expressing PC12 Cell Lines {#Sec3}
------------------------------------------------------------

Cell lines expressing MAO-B under transcriptional regulation by doxycycline (dox) (Kumar et al. [@CR13]) were maintained in DMEM containing 10% FBS, 5% horse serum, and 1% streptomycin--penicillin in the presence of 200 μg/ml of G418; the cells were neuronally differentiated via exposure to 50 ng/ml nerve growth factor (NGF) for a 2 day period before addition of dox to induce MAO-B elevations.

Mitochondrial Preparation {#Sec4}
-------------------------

Mitochondria were prepared by homogenizing cells in mitochondrial medium containing 320 mM sucrose, 5 mM TES, and 1 mM EGTA, centrifuging the homogenate at 1000×*g*, and pelleting the mitochondria in the resulting supernatant at 10000×*g*. The mitochondria were resuspended in 250 mM sucrose, 10 mM TES, and 0.1% (w/v) fatty acid free BSA, pH 7.2 for complex I, KGDH, and citrate synthase assays.

Complex I Activity {#Sec5}
------------------

Activity was assayed in homogenates from isolated mitochondria as rotenone-sensitive NADH dehydrogenase activity by measuring 2,6-dichlorophenolindophenol (DCIP) reduction in mitochondrial extract following addition of 200 μM NADH, 200 μM decylubiquinone, 2 mM KCN, and 0.002% DCIP in the presence and absence of 2 μM rotenone (Trounce et al. [@CR31]). Values for this and all subsequent assays were normalized per protein using BioRad reagent.

KGDH Activity {#Sec6}
-------------

KGDH activity was assayed as the rate of NAD^+^ reduction at 340 nm upon addition of 5.0 mM MgCl~2~, 40.0 μM rotenone, 2.5 mM α-ketoglutarate, 0.1 mM CoA, 0.2 mM thymine pyrophosphate, and 1.0 mM NAD to freeze-thawed mitochondria (Nulton-Persson and Szweda [@CR21]). Citrate synthase activity, used to normalize the mitochondrial load, was measured by assessing the change in A~412~ reduction of 2.0 mM DTNB in presence of 6 mM acetyl CoA and 10 mM oxaloacetate (Trounce et al. [@CR31]).

Aconitase Activity {#Sec7}
------------------

Aconitase activity was assayed as the rate of NADP^+^ reduction at 340 nm upon addition of 30 mM sodium citrate, 0.6 mM fresh MnCl~2,~ 0.2 mM NADP^+^, and 2 U/ml isocitrate dehydrogenase in 25 mM KH~2~PO~4~ pH 7.4, 0.5 mM EDTA to the mitochondrial preparation.

SDH Activity {#Sec8}
------------

Succinate dehydrogenase activity was assayed as DCIP reduction at 600 nm upon addition of 20 mM succinate, 2 mM KCN, 200 μM decylubiquinone, and 0.002% DCIP in 25 mM KH~2~PO~4~ pH 7.4, 0.5 mM EDTA to the mitochondria preparation after activation for 15 min at 30°C to compete out oxaloacetic acid (OAA) in the presence of succinate and KCN.

PDH Activity {#Sec9}
------------

Pyruvate dehydrogenase was assayed as the reduction of DTNB at 412 nm by first incubating the mitochondrial preparation in the solution containing 2 mM TPP, 10 mM DTT and 10 mM sodium pyruvate, 1 mM MgCl~2~, and 2 mM NAD^+^, with or without 0.2 mM sodium Co-A for 15 min at 30°C followed by addition of 25 mM OAA and 0.05% DTNB, equilibrating for 10 min, and addition of 5 U/ml citrate synthase. The difference change in absorbance over time at 412 nm was recorded in the absence or presence of sodium Co-A.

Oxygen Consumption {#Sec10}
------------------

Substrate-specific respiration was assayed in fresh mitochondrial preparations from dox-induced and uninduced cells in a buffer containing 125 mM KCl, 2 mM KH~2~PO~4~, 1 mM MgCl~2~, and 20 mM HEPES pH 7.0 (Murphy et al. [@CR20]) at 30°C using a Clarke electrode (Hansatech). Respiration was calculated as the rate of oxygen consumption using either 5.0 mM pyruvate/5.0 mM malate as substrates for PDH, 5.0 mM citrate/5.0 mM malate as substrates for aconitase, 5.0 mM glutamate/5.0 mM malate as substrates for complex I, or 5.0 mM α-ketoglutarate/5.0 mM malate as substrates for KGDH in presence or absence of selective inhibition with 0--100 nM arsenite (KGDH) or 2.0 μM rotenone (complex I), respectively. FCCP (10 μM) was added as uncoupler to assess maximum respiration rates.

Inhibitor Titrations {#Sec11}
--------------------

Inhibitor titrations were performed to assess threshold values and control coefficients. Specific enzyme inhibitors used for titration included arsenite/bromopyruvate for PDH, arsenite alone for KGDH, fluorocitrate for aconitase, malonate for SDH, and rotenone for complex I-mediated respiration analyses. To allow maximal contribution of every component enzyme, respiration was also carried out using a mixed cocktail of substrates containing 5 mM each of pyruvate, malate, citrate, α-ketoglutarate, and glutamate in the presence of specific separate inhibitors to titrate out individual enzymes. Since arsenite is not specific for KGDH, respiration mediated by KGDH alone was also assayed in the presence of 20 mM bromopyruvate to inhibit PDH and its effects. The inhibitor concentrations used were determined by using close approximations of the published *K*. Relative dissociation constants pertinent for each enzyme were calculated using a derivation of the Michaelis--Menten equation, *K*~d~ = \[*I*\]/((*V*~o~/*V*~i~) − 1), where *V*~i~ is the inhibited rate of enzyme, *V*~o~ is the initial rate and \[*I*\] is the inhibitor concentration. For our purposes, a *V*~o~ was set at a relative 100% and *V*~i~ at a point close but not equal to zero where the enzyme activity is minimal. Control coefficients quantitatively describe the control exerted by each enzyme in a metabolic network over substrate flux (Cascante et al. [@CR3]). We calculated the control coefficients (*C*~i~) of respiration of the component enzymes using the equation (Davey et al. [@CR9]):$$\documentclass[12pt]{minimal}
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Statistical analysis {#Sec12}
--------------------

Data is expressed as mean ± SD and significance testing was performed using ANOVA.

Results {#Sec13}
=======

MAO-B Mediated H~2~O~2~ Generation Inhibits Mitochondrial Enzymes {#Sec14}
-----------------------------------------------------------------

To study the effects of H~2~O~2~ generated by inducible increases in MAO-B levels on individual respiratory components in our dopaminergic cell system (Kumar et al. [@CR13]), we measured enzyme activities in mitochondrial preparations from uninduced versus dox-induced cells expressing MAO-B in either the absence or presence of the MAO-B inhibitor deprenyl. MAO-B elevation was found to substantially inhibit mitochondrial aconitase, KGDH, complex I, succinate dehydrogenase, and PDH activities to an extent ranging from 33.5% to nearly 60%; these inhibitions were deprenyl-sensitive (Fig. [1](#Fig1){ref-type="fig"}) and prevented by catalase pretreatment (Kumar et al. [@CR13]) (data not shown for aconitase, SDH and PDH) suggesting that they were both MAO-B and H~2~O~2~-dependent.Fig. 1Mitochondrial enzyme activities are inhibited via MAO-B elevation. Activities of the major mitochondrial enzymes involved in NADH/FADH production were measured in mitochondrial preparations from uninduced (*left bars*), dox-induced (*middle bars*) and dox-deprenyl co-treated cells (*right bars*). *n* = 5 per condition from three separate experiments, values are expressed as mean ± SD, \**P* \< 0.01 compared to no dox

Respiratory Thresholds and Spare Capacities {#Sec15}
-------------------------------------------

Specific inhibitor titrations were initially performed in order to identify the appropriate inhibitor range to be used for each enzyme. This inhibitor range was subsequently used to perform measurements of substrate-specific respiration. Enzyme inhibition versus respiration was plotted for each enzyme in order to determine respiratory thresholds and spare capacities for each in the absence and presence of MAO-B induction (Fig. [2](#Fig2){ref-type="fig"}, Table [1](#Tab1){ref-type="table"}).Fig. 2Alterations in respiratory threshold values of NADH-dependent enzymes under conditions of MAO-B-induced stress. Inhibitor titrations of uncoupled substrate dependent respiration were plotted against relative inhibition of activity by enzyme-specific specific inhibitors in mitochondria isolated from uninduced control cells (*blue*) versus dox-induced cells expressing elevated MAO-B levels (*red*). The curves, plotted as trends of the data points shown are: fluorocitrate inhibition of mitochondrial aconitase (**a**), rotenone inhibition of CI (**b**), malonate inhibition of SDH (**c**), bromopyruvate (BrPy) inhibition of PDH (**d**), arsenite inhibition of KGDH (**e**), and arsenite inhibition of KGDH in a background of a total inhibition of PDH by BrPy (**f**). Threshold values are calculated as the abscissa at 0% inhibition on the trends drawn at maximal inhibition. The straight equations represent the respective uninduced (*blue*) and induced (*red*) trends drawn at near total inhibition of uncoupled respiration and activity by the enzyme-specific inhibitor. Respiratory spare capacity is derived by the difference between maximum respiration (100%) and the '*y*' intercept of the trend line (at zero inhibition). Dotted trends and equations at initial points in the curve are used for calculation of the control coefficients. Actual maximal and minimal respiration and activity is adjusted to 100 and 0 percent values to enable comparison and residual inhibitor independent respiration by the mitochondria has been discounted to facilitate comparative analysisTable 1Spare capacities and threshold valuesEnzyme% Spare capacity% Threshold value of inhibitionUninducedInducedUninducedInducedReductionAconitase189.0389.4966.0247.4818.54αKGDH57.064.9536.054.6031.45αKGDH with (BrPy)62.79\<038.76−4.9543.71Complex I7.30\<07.17−3.3710.54SDH249.47196.2073.8367.915.92PDH415.62347.9281.6376.635.00Respiratory spare capacity and the threshold value of inhibition of respiration derived from inhibitor titration of each the mitochondrial enzymes examined. Spare capacity represents maximal uncoupled oxygen consumption during complete enzyme inhibition. Threshold values reflect total inhibition of activity necessary before respiration is affected and the reduction of the threshold value represents the shift resulting from MAO-B induction. The values are represented as % changes from uninhibited maximal uncoupled oxygen consumption

Aconitase was found to have a spare capacity of 189% that is reduced to 89% following MAO-B induction as indicated by the intercept of the slope at the point of total respiratory inhibition (Fig. [2](#Fig2){ref-type="fig"}a). The threshold value was determined to be reduced by 19% in MAO-B-expressing versus control conditions (66% vs. 47%, Table [1](#Tab1){ref-type="table"}).

Complex I was found to have a very low spare capacity (7%) that was reduced to zero by MAO-B increase (Fig. [2](#Fig2){ref-type="fig"}b). The threshold value of 7.2% in uninduced cells was reduced to a negative value of 3.37% following MAO-B induction, a total shift of 10.54 (Table [1](#Tab1){ref-type="table"}). This alteration was mirrored when respiration was measured using a substrate mix instead of glutamate/malate alone.

SDH and PDH, though vastly different enzyme complexes, behaved in a similar fashion in this study. Mitochondria have a very high capacity to consume oxygen using specific substrates for these enzyme complexes; both enzymes require significant inhibition before respiratory capacity is diminished (Fig. [2](#Fig2){ref-type="fig"}). Though both these enzymes have sensitivity to hydrogen peroxide as reflected by the MAO-B induced reduction in their specific activities (Fig. [1](#Fig1){ref-type="fig"}), they appear to have a very high uninduced spare capacity, 250% and 415%, respectively (Table [1](#Tab1){ref-type="table"}, Fig. [2](#Fig2){ref-type="fig"}c, d). MAO-B elevation reduces this spare capacity only slightly, from 250% to 196% in the case of SDH and 415% to 348% in the case of PHD. Threshold values were determined to be 74% and 82% inhibition, respectively, which transitioned only slightly following MAO-B increase (68% and 77%, respectively, Table [1](#Tab1){ref-type="table"}).

For KDGH, we observed a decrease from 57% spare capacity to 5% under conditions of MAO-B elevation and the threshold value for inhibition by arsenite was shifted from 36% to 4.6% under this stress condition (Fig. [2](#Fig2){ref-type="fig"}e, Table [1](#Tab1){ref-type="table"}). Since KGDH is structurally and catalytically similar to pyruvate PDH and therefore conditions that inhibit the former may inhibit PDH as well, we also assessed KDGH inhibition and titration of arsenite-sensitive KGDH dependent respiration in the presence of the specific PDH inhibitor, bromopyruvate. In order to mimic cellular conditions where substrate levels are not limiting, we used a substrate mixture that included all those specific for the enzymes being examined in our studies. Succinate addition was avoided since SDH displayed an overwhelming control over respiration masking the contribution from other components (data not shown). Similar assessment of effects of titration using other inhibitors in the presence of a mixed substrate cocktail without succinate yielded similar results (data not shown). We found that under conditions in which PDH is inhibited by bromopyruvate, KDGH had a higher threshold value (62.8%) which dropped to zero in the presence of MAO-B increase (Fig. [2](#Fig2){ref-type="fig"}f). The threshold of inhibition by arsenite was found to shift from 38.8% to less than zero in the presence of up-regulation of MAO-B (Table [1](#Tab1){ref-type="table"}).

Control Coefficients {#Sec16}
--------------------

Flux control analysis (Kacser and Burns [@CR11], [@CR12]) represents an approach that can provide important insights into the functional role of the respiratory chain in various conditions. If a metabolic pathway is composed of distinct enzymes, the extent to which each enzyme is rate-controlling may be different and the sum of all the flux control coefficients for the different enzymes should be equal to unity (Kacser and Burns [@CR12]; Brand et al. [@CR2]). In our experiments, the enzymes examined are various contributors to the final end-product, i.e., NADH, which is then oxidized as substrate by CI thus initiating the mitochondrial oxidative phosphorylation cycle. SDH contributes to this at two levels---first during the TCA cycle and later during ubiquinone reduction. The reactions measured therefore could be part of a branched pathway and hence the flux control coefficients could total greater than one (Cornish-Bowden [@CR6]). In order to acquire an elementary understanding of relative contributions of the participant enzymes on total NADH generation in particular and on oxidative phosphorylation in general, we measured the relative change in control coefficients between the two conditions, i.e., the uninduced control and in the presence of MAO-B mediated H~2~O~2~ generation (Table [2](#Tab2){ref-type="table"}). Increased levels of MAO-B resulted in a shift in the metabolic control of respiration. Interestingly, CI was found to exert maximal respiratory control in both basal conditions (flux coefficient, 0.36 and following MAO-B induction (doubled to 0.65).Table 2Respiratory flux control coefficientsEnzyme*K*~d~ (inhibitor)*C*~i~UninducedInducedFold changeAconitaseFluorocitrate2.88 μM0.00860.01802.10αKGDHArsenite2.97 nM0.06910.11201.62αKGDH with (BrPy)Arsenite2.97 nM0.07770.75609.73Complex IRotenone43.19 nM0.36110.64571.79SDHMalonate34.33 μM0.07630.06440.84PDHBromopyruvate2.63 μM0.03150.02950.94$\documentclass[12pt]{minimal}
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Discussion {#Sec17}
==========

Investigation of mitochondrial oxidative phosphorylation using metabolic control analysis (MCA) allows examination of the contribution of various metabolic activities on disease states involving mitochondrial dysfunction. Measurement of the impact of increasing concentrations of specific inhibitors on enzyme activities versus substrate-specific respiration is used to obtain titration curves for graphical determination of flux control coefficients, an index of each component enzyme's contribution to mitochondrial function (Cascante et al. [@CR3]). Determination of the control coefficients within a given pathway determines which portion of the pathway is rate-limiting and can indicate the most efficient point of intervention. This utility can be exploited to identify key targets in disease pathways leading to drug discovery. As an example, moderate effects on the activities of respiratory chain components upstream and including cytochrome oxidase (COX) by either inhibitors, mutations or physiological changes can result in dramatic changes in COX threshold and respiratory control by the enzyme, thereby affecting a disease phenotype (Villani and Attardi [@CR32]). Though MCA is probably too simple to account for the complexity of all disease-related enzymes, it has revealed the existence of thresholds in terms of enzymatic defects in oxidative phosphorylation associated with known mitochondrial disease mutations that impact on fluxes associated with enzymatic reserve (Mazat et al. [@CR17]). Disease manifestation was found in these cases to only appear when the activity of a metabolic step had been reduced to a low level. Threshold effects have been used for the functional determination of different mitochondrial defects, often by measuring maximal rates of respiration and the effect of specific inhibitors (Davey et al. [@CR8], [@CR9]; Letellier et al. [@CR16]; Villani et al. [@CR33]; Davey and Clark [@CR7]). The significance of alterations in the activities of individual mitochondrial bioenergetic components cannot be fully assessed in terms of mitochondrial function without an assessment of the relative control strengths of each component (Harper et al. [@CR10]).

In this study, we attempted to perform a limited MCA of various enzymes affecting respiratory rates especially under a condition of increased oxidative stress as a consequence of MAO-B elevation. Generation of H~2~O~2~ via increased MAO-B levels akin to that observed in aging and neurodegenerative disease results in metabolic stress within the respiratory apparatus by affecting components contributing to NADH levels. Upon MAO-B induction, activity of all the enzymes examined diminishes and the maximal respiration which can be supported was found to be decreased. The spare capacity and the respiratory threshold of each enzyme were found to be reduced to varying degrees, near zero in the case of both Complex I and KDGH under the high energy demand conditions examined.

Under non-stress conditions, the sum of the control coefficients of all components examined is 0.6153, indicating that there are likely other contributors to metabolic control in the uninduced cells. In the stress condition, the sum of control coefficients of all components examined increases to 0.9473, indicating that the enzymes studied have a large control over respiration in this situation. Mitochondrial CI has been reported to be particularly sensitive to oxidative stress and its inhibition hypothesized to play a major role in mitochondrial dysfunction associated with PD (Schapira et al. [@CR25]; Mizuno et al. [@CR18]; Lenaz et al. [@CR15]). We found that it plays a major role in our system under both control and MAO-B induced conditions. The spare capacity and threshold of inhibition of KDGH also appears to be reduced to zero under the stress conditions examined in this study. KGDH too has been reported to be sensitive to damage by H~2~O~2~ and itself is a source of H~2~O~2~ when substrate-limited (Tretter and Adam-Vizi [@CR30]; Starkov et al. [@CR27]). Other mitochondrial enzymes are also affected in our model but with less effect on their spare capacities or inhibition thresholds. PDH has been reported to be impacted by H~2~O~2~ generated during ischemia (Bogaert et al. [@CR1]; Samikkannu et al. [@CR23]; Tabatabaie et al. [@CR28]). Similarly, SDH has also been reported to be sensitive to H~2~O~2~ (Nulton-Persson and Szweda [@CR21]; Tretter and Adam-Vizi [@CR29]). Our data indicates that although all the enzymes examined are inhibited under MAO-B induced stress, there is a vast difference in the control they exert on mitochondrial respiration. CI inhibition by MAO-B induced stress appears to be more important than inhibition of the other enzymes examined in this study suggesting that intervention to prevent dopaminergic mitochondrial dysfunction should be directed toward preservation of CI activity although KGDH may also be of some import especially when its effects are separated from PDH activity.
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